Literature DB >> 10952686

Insulin-like effect of pinitol.

S H Bates1, R B Jones, C J Bailey.   

Abstract

D-pinitol (3-O-methyl-chiroinositol), an active principle of the traditional antidiabetic plant Bougainvillea spectabilis, is claimed to exert insulin-like effects. This study investigates the effect of D-pinitol on glucose homeostasis in animal models of diabetes, and on glucose transport by cultured muscle cells. Plasma glucose concentrations were measured in normal, obese-diabetic (ob/ob) and streptozotocin (STZ)-diabetic mice after oral (p.o.) and intraperitoneal (i.p.) administration of D-pinitol. Glucose transport was measured in L6 rat muscle cells by 2-deoxyglucose (2DG) uptake. In STZ-diabetic mice, 100 mg kg(-1) p.o. D-pinitol acutely decreased the hyperglycaemia (by 22% at 6 h). A similar decrease in plasma glucose (by 21%) was observed after 100 mg kg(-1) i.p. D-pinitol. Insulin concentrations and the rate of insulin-induced (1 unit kg(-1) actrapid i.p.) glucose disappearance were not altered by 100 mg kg(-1) p.o. D-pinitol. Chronic administration of D-pinitol (100 mg kg(-1) i.p. twice daily for 11 days) to STZ-diabetic mice maintained a reduction in plasma glucose concentrations from about 14 to 10 mmol l(-1). In normal non-diabetic and severely insulin resistant ob/ob mice, 100 mg kg(-1) p.o. D-pinitol did not significantly affect plasma glucose or insulin during acute studies. Incubation of L6 muscle cells with D-pinitol (10(-3) M) increased basal 2DG uptake by 41% after 10 min and by 34% after 4 h. The effect of D-pinitol was inhibited by the phosphatidylinositol 3-kinase inhibitor LY294002. D-pinitol did not increase insulin-stimulated 2DG uptake by L6 cells. The data support the view that D-pinitol can exert an insulin-like effect to improve glycaemic control in hypoinsulinaemic STZ-diabetic mice. D-pinitol may act via a post-receptor pathway of insulin action affecting glucose uptake.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952686      PMCID: PMC1572278          DOI: 10.1038/sj.bjp.0703523

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

Review 1.  From receptor to transporter: insulin signalling to glucose transport.

Authors:  G D Holman; M Kasuga
Journal:  Diabetologia       Date:  1997-09       Impact factor: 10.122

2.  Determination of glucose by an automatic analyser.

Authors:  J F Stevens
Journal:  Clin Chim Acta       Date:  1971-04       Impact factor: 3.786

3.  Retention of differentiation potentialities during prolonged cultivation of myogenic cells.

Authors:  D Yaffe
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

4.  Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice.

Authors:  P R Flatt; C J Bailey
Journal:  Diabetologia       Date:  1981-05       Impact factor: 10.122

5.  Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice.

Authors:  C J Bailey; P R Flatt; T W Atkins
Journal:  Int J Obes       Date:  1982

6.  Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo.

Authors:  L C Huang; M C Fonteles; D B Houston; C Zhang; J Larner
Journal:  Endocrinology       Date:  1993-02       Impact factor: 4.736

7.  Chiroinositol deficiency and insulin resistance. II. Acute effects of D-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistant rhesus monkeys.

Authors:  H K Ortmeyer; L C Huang; L Zhang; B C Hansen; J Larner
Journal:  Endocrinology       Date:  1993-02       Impact factor: 4.736

8.  Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes.

Authors:  D R Poyner; D P Andrew; D Brown; C Bose; M R Hanley
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

9.  Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.

Authors:  A S Kennington; C R Hill; J Craig; C Bogardus; I Raz; H K Ortmeyer; B C Hansen; G Romero; J Larner
Journal:  N Engl J Med       Date:  1990-08-09       Impact factor: 91.245

10.  Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes.

Authors:  S Suzuki; H Kawasaki; Y Satoh; M Ohtomo; M Hirai; A Hirai; S Hirai; M Onoda; M Matsumoto; Y Hinokio
Journal:  Diabetes Care       Date:  1994-12       Impact factor: 19.112

View more
  32 in total

Review 1.  The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

Authors:  Mark P Thomas; Stephen J Mills; Barry V L Potter
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-22       Impact factor: 15.336

2.  Spotlight on ethnomedicine: usability of Sutherlandia frutescens in the treatment of diabetes.

Authors:  Charles Sia
Journal:  Rev Diabet Stud       Date:  2004-11-10

3.  Sutherlandia frutescens: the meeting of science and traditional knowledge.

Authors:  Oluwaseyi M Aboyade; Gustav Styger; Diana Gibson; Gail Hughes
Journal:  J Altern Complement Med       Date:  2013-07-09       Impact factor: 2.579

4.  Herbal constituent sequoyitol improves hyperglycemia and glucose intolerance by targeting hepatocytes, adipocytes, and β-cells.

Authors:  Hong Shen; Mengle Shao; Kae Won Cho; Suqing Wang; Zheng Chen; Liang Sheng; Ting Wang; Yong Liu; Liangyou Rui
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-31       Impact factor: 4.310

5.  Protective effect of D-pinitol on the experimental spinal cord injury in rats.

Authors:  Yan An; Jianing Li; Yajun Liu; Mingxing Fan; Wei Tian
Journal:  Metab Brain Dis       Date:  2020-01-29       Impact factor: 3.584

6.  D-chiro-inositol negatively regulates the formation of multinucleated osteoclasts by down-regulating NFATc1.

Authors:  Jungeun Yu; Seunga Choi; Eui-Soon Park; Bongjin Shin; Jiyeon Yu; Seoung Hoon Lee; Masamichi Takami; Jong Soon Kang; Hyungun Meong; Jaerang Rho
Journal:  J Clin Immunol       Date:  2012-06-19       Impact factor: 8.317

Review 7.  New pharmacologic agents for diabetes.

Authors:  C J Bailey
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

8.  Soy pinitol acts partly as an insulin sensitizer or insulin mediator in 3T3-L1 preadipocytes.

Authors:  Gyeong-Min Do; Myung-Sook Choi; Hye-Jin Kim; Myung-Nam Woo; Mi-Kyung Lee; Seon-Min Jeon
Journal:  Genes Nutr       Date:  2008-02       Impact factor: 5.523

9.  Determination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients.

Authors:  Tae-Sik Jung; Jong-Ryeal Hahm; Jong-Jin Kim; Jung-Hwa Jung; Mi-Yeon Kang; Sung-Won Moon; Kang-Wan Lee; Ho-Cheol Kim; Jong-Deog Lee; Ji-Hye Kim; Deok-Ryong Kim; Soon-Il Chung
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

10.  Effects of acute pinitol supplementation on plasma pinitol concentration, whole body glucose tolerance, and activation of the skeletal muscle insulin receptor in older humans.

Authors:  A J Stull; K V Wood; J P Thyfault; W W Campbell
Journal:  Horm Metab Res       Date:  2009-02-16       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.